Case report: A safeguard in the sea of variants of uncertain significance: a case study on child with high risk neuroblastoma and acute myeloid leukemia

Case report: A safeguard in the sea of variants of uncertain significance: a case study on child with high risk neuroblastoma and acute myeloid leukemia

The increased availability of genetic technologies has significantly improved the detection of novel germline variants conferring a predisposition to tumor development in patients with malignant disease. The identification of variants of uncertain significance (VUS) represents a challenge for the cl...

Full description

Bibliographic Details
Main Authors:	Francesco Fabozzi, Rosalba Carrozzo, Mariachiara Lodi, Angela Di Giannatale, Selene Cipri, Chiara Rosignoli, Isabella Giovannoni, Alessandra Stracuzzi, Teresa Rizza, Claudio Montante, Emanuele Agolini, Michela Di Nottia, Federica Galaverna, Giada Del Baldo, Francesco Del Bufalo, Angela Mastronuzzi, Maria Antonietta De Ioris
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-01-01
Series:	Frontiers in Oncology
Subjects:	cancer predisposition syndrome succinate dehydrogenase complex subunit C (SHDC) gene variants of uncertain significance (VUS) neuroblastoma acute myeloid leukemia
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1324013/full

Similar Items

A Functional Analysis of the Unclassified Pro2767Ser BRCA2 Variant Reveals Its Potential Pathogenicity that Acts by Hampering DNA Binding and Homology-Mediated DNA Repair
by: Maria Valeria Esposito, et al.
Published: (2019-09-01)

Unlocking the power of precision medicine for pediatric low-grade gliomas: molecular characterization for targeted therapies with enhanced safety and efficacy
by: Selene Cipri, et al.
Published: (2023-06-01)

Hemophagocytic Lymphohistiocytosis Gene Variants in Multisystem Inflammatory Syndrome in Children
by: Anshul Vagrecha, et al.
Published: (2022-03-01)

Usefulness and Limitations of Comprehensive Characterization of mRNA Splicing Profiles in the Definition of the Clinical Relevance of BRCA1/2 Variants of Uncertain Significance
by: Elisa Gelli, et al.
Published: (2019-03-01)

Hemimegalencephaly and Epileptic Encephalopathy Associated with a Variant of Uncertain Significance of the TRIO Gene
by: Eugenia ROZA, et al.
Published: (2022-06-01)

Targeted therapy for pediatric central nervous system tumors harboring mutagenic tropomyosin receptor kinases
by: Selene Cipri, et al.
Published: (2023-12-01)

Case report: A new pathogenic variant of LRBA deficiency with a complex phenotype and Rosai-Dorfman disease
by: Francesco Fabozzi, et al.
Published: (2022-12-01)

The Fight Just Born—Neonatal Cancer: Rare Occurrence with a Favorable Outcome but Challenging Management
by: Maria Antonietta De Ioris, et al.
Published: (2022-04-01)

Prevalence and reclassification of BRCA1 and BRCA2 variants in a large, unselected Chinese Han breast cancer cohort
by: Yun Liu, et al.
Published: (2021-01-01)

MAGI-ACMG: Algorithm for the Classification of Variants According to ACMG and ACGS Recommendations
by: Francesca Cristofoli, et al.
Published: (2023-08-01)

Molecular Modelling Hurdle in the Next-Generation Sequencing Era
by: Guerau Fernandez, et al.
Published: (2022-06-01)

Central Nervous System Metastasis in Neuroblastoma: From Three Decades Clinical Experience to New Considerations in the Immunotherapy Era
by: Angela Mastronuzzi, et al.
Published: (2022-12-01)

Functional Evaluation of Splicing for Variants of Uncertain Significance in Patients with Inherited Retinal Diseases
by: Margarita Mauro-Herrera, et al.
Published: (2021-06-01)

Possible A2E Mutagenic Effects on RPE Mitochondrial DNA from Innovative RNA-Seq Bioinformatics Pipeline
by: Luigi Donato, et al.
Published: (2020-11-01)

Editorial: Pathogenic mechanisms in neurodevelopmental disorders: advances in cellular models and multi-omics approaches
by: R. Hollstein, et al.
Published: (2023-10-01)

Editorial: Accomplishments, Collaborative Projects and Future Initiatives in Breast Cancer Genetic Predisposition
by: Paolo Peterlongo, et al.
Published: (2019-08-01)

Gene mutations: Understanding the significance using in silico analysis
by: K Sanjana Pillay
Published: (2015-01-01)

The E273del variant of uncertain significance of the ornithine transcarbamylase gene - a case for reclassification
by: Nicole Ducich, et al.
Published: (2020-06-01)

Novel mutations in actionable breast cancer genes by targeted sequencing in an ethnically homogenous cohort
by: Hosneara Akter, et al.
Published: (2019-09-01)

The Pitfall of Ganglioneuroblastoma-Nodular Diagnosis: Clinical and Imaging Considerations over a Rare Bifocal Sporadic Case
by: Claudio Montante, et al.
Published: (2022-12-01)

Venetoclax plus cyclophosphamide and topotecan in heavily pre-treated relapsed metastatic neuroblastoma: a single center case series
by: Maria Antonietta De Ioris, et al.
Published: (2023-11-01)

How Genetics and Genomics Advances Are Rewriting Pediatric Cancer Research and Clinical Care
by: Selene Cipri, et al.
Published: (2022-10-01)

Our Experience with Contrast-Enhanced Voiding Urosonography
by: Karla Rubelj, et al.
Published: (2021-01-01)

Prevalence of Variants of Uncertain Significance in Patients Undergoing Genetic Testing for Hereditary Breast and Ovarian Cancer and Lynch Syndrome
by: Pavlina Chrysafi, et al.
Published: (2023-12-01)

A novel BRCA2 splice variant identified in a young woman
by: Arianna Nicolussi, et al.
Published: (2020-12-01)

A new direction for prenatal chromosome microarray testing: software-targeting for detection of clinically significant chromosome imbalance without equivocal findings
by: Joo Wook Ahn, et al.
Published: (2014-04-01)

An Algorithm Combining Patient Performance Status, Second Hit Analysis, PROVEAN and Dann Prediction Tools Could Foretell Sensitization to PARP Inhibitors in Digestive, Skin, Ovarian and Breast Cancers
by: Sandy Chevrier, et al.
Published: (2021-06-01)

Comprehensive Identification of Deleterious <i>TP53</i> Missense VUS Variants Based on Their Impact on TP53 Structural Stability
by: Benjamin Tam, et al.
Published: (2021-10-01)

Characterization of a de novo GABBR2 variant linked to autism spectrum disorder
by: Noa Bielopolski, et al.
Published: (2023-11-01)

Germline variants of uncertain significance, their frequency, and clinico-pathological features in a cohort of Sri Lankan patients with hereditary breast cancer
by: Kawmadi Gunawardena, et al.
Published: (2023-06-01)

Gene-specific machine learning model to predict the pathogenicity of BRCA2 variants
by: Mohannad N. Khandakji, et al.
Published: (2022-09-01)

Identification of the Germline Mutation Profile in Esophageal Squamous Cell Carcinoma by Whole Exome Sequencing
by: Jiaying Deng, et al.
Published: (2019-02-01)

Trans-activation-based risk assessment of BRCA1 BRCT variants with unknown clinical significance
by: Jonas Langerud, et al.
Published: (2018-11-01)

Rates of Variants of Uncertain Significance Among Patients With Breast Cancer Undergoing Genetic Testing: Regional Perspectives
by: Hikmat Abdel-Razeq, et al.
Published: (2022-03-01)

Cerebellar mutism syndrome: From pathophysiology to rehabilitation
by: Francesco Fabozzi, et al.
Published: (2022-12-01)

An in silico toolbox for the prediction of the potential pathogenic effects of missense mutations in the dimeric region of hRPE65
by: Giulio Poli, et al.
Published: (2023-12-01)

Biallelic <i>PMS2</i> Mutations in a Family with Uncommon Clinical and Molecular Features
by: Monica Pedroni, et al.
Published: (2022-10-01)

Clinical utility of periodic reinterpretation of CNVs of uncertain significance: an 8-year retrospective study
by: Jean-Marie Ravel, et al.
Published: (2023-05-01)

Evaluation of a 27-gene inherited cancer panel across 630 consecutive patients referred for testing in a clinical diagnostic laboratory
by: Sabrina A. Gardner, et al.
Published: (2018-01-01)

Classification of VUS and unclassified variants in BRCA1 BRCT repeats by molecular dynamics simulation
by: Siddharth Sinha, et al.
Published: (2020-01-01)